Q1 FY22 - 22 April 2022

Release approved by Brian Lane, CFO Visioneering Technologies Inc.

ASX:VTI

VTI-IR-ASX61

Legal Information

Summary

The material contained in this presentation is intended to be general background information about Visioneering Technologies, Inc. ("VTI", or "Visioneering") and its activities.

The information is provided in a summary form, does not purport to be complete and may include information derived from publicly available sources that have not been independently verified. Accordingly, this presentation should not be relied upon as advice for investors or potential investors. It should be read in conjunction with VTI's periodic and continuous disclosure announcements lodged with the Australian Securities Exchange ("ASX"), which are available atwww.asx.com.au.

No representation or warranty is made as to the accuracy, completeness or reliability of the information.

Past performance, including the pro forma historical information in this presentation is given for illustrative purposes only and should not be relied on (and is not) an indication of future performance including future security price information. Historical information in this presentation relating to VTI is information that has been released to the market. For further information, please see past announcements released to the ASX. Nothing contained in this presentation nor any information made available to investors or potential investors is, or shall be relied upon as, a promise, representation, warranty or guarantee, whether as to the past, present or future.

Past performance is not necessarily a guide to future performance and no representation or warranty is made as to the likelihood of achievement or reasonableness of any forward looking statements or other forecast.

CHESS Depositary Interests

No financial product advice

This presentation is for information purposes only and does not take into account the investment objectives, financial position or needs of any particular investor. Investors or potential investors should seek independent professional advice in respect of their specific investment objectives, financial situation and particular needs before making any investment decision. VTI is not licensed to provide financial product advice in respect of its securities or any other financial products.

VTI's CHESS Depositary Interests (CDIs) are traded on ASX in reliance on the safe harbour provisions of Regulation S under the US Securities Act of 1933, as amended, and in accordance with the procedures established pursuant to the provisions of a no-action letter dated 7 January 2000 given to ASX by the staff at the US Securities and Exchange Commission. The relief was given subject to certain procedures and conditions described in the no-action letter. One of the conditions is that the issuer provides notification of the Regulation S status of its securities in communications such as this presentation.

Risks

No offer

An investment in VTI is subject to known and unknown risks, some of which are beyond the control of VTI and its directors. VTI does not guarantee any particular rate of return in relation to VTI securities or the performance of VTI.

Forward-looking statements

Certain statements in this presentation may constitute forward-looking statements or statements about future matters that are based on management's current expectations and beliefs (being statements about matters that are not historical facts), including but not limited to, statements related to VTI's financial performance, business strategy and goals, plans and prospects, potential benefits of VTI's products and technology, product development, timing of international regulatory approvals, market size, commercial success, and future financial performance. VTI uses words such as 'will', 'may', 'expect', 'intend', 'seek', 'would', 'should', 'could', 'continue', 'plan', 'estimate', 'anticipate', 'believe', 'probability', 'risk', 'aim', or other similar words to identify forward- looking statements.

These forward-looking statements are subject to risks and uncertainties that are difficult to predict and are based on assumptions as to future events that may not prove accurate.

Given the current uncertainties regarding the on-going impact of the COVID-19 on the trading conditions impacting VTI, the financial markets and the health services world-wide, there can be no assurance that future developments will be in accordance with VTI's expectations or that the effect of future developments on VTI will be those anticipated. Actual results may differ materially from what is expressed in this presentation and investors are cautioned not to place undue reliance on the current trading outlook.

Past performance

This presentation is for information purposes only and is not and should not be considered an offer or an invitation to acquire securities or any other financial products in any jurisdiction in which, or to any person to whom, it would be unlawful to make such an offer or invitation.

Each recipient of this presentation should make its own enquiries and investigations regarding all information included in this presentation including the assumptions, uncertainties and contingencies which may affect VTI's future operations and the values and the impact that future outcomes may have on VTI.

The information in this presentation is subject to change and unless required by law, VTI is under no obligation to update this presentation (including any forward-looking statements) or its contents for any matter arising or coming to VTI's notice after the date of this presentation.

None of VTI, its officers, directors, employees and agents, nor any other person makes any representation or warranty, express or implied, as to, or endorsement of, VTI, the accuracy or completeness of any information, statements or representations contained in this presentation and none of them accepts responsibility or liability for any errors or omissions in this presentation whatsoever.

This document may not be reproduced or published, in whole or in part, for any purpose without the prior written consent of VTI. The distribution of this presentation outside of Australia may be restricted by law and any such restrictions should be observed.

This presentation does not constitute an offer to sell, or a solicitation of an offer to buy, securities in Australia, the U2nited States or any other jurisdiction.

Vision correction

Our flagship contact lenses NaturalVue MF, address two high- need and underserved populations worth up to $25bn combined:

$13-17bn global TAM

$8bn global TAM

  • • Affects up to one-third of children in US and 80-90% of children in many Asian nations, 2 billion people worldwide

    • • Affects nearly everyone over 45-50 in every part of the world

  • • Quarantine has likely increased rates (J. Am Med Assoc, 2021)

    • • Progressive disease; worsens with age

      Near-

  • • Correlates to elevated life-time risk for blindness and other debilitating

    • • Current contact lenses for presbyopia compromise either near

      sightedness or "Myopia"

      ocular diseases

  • • Risk for ocular diseases correlates with level of near sightedness

    Adults over 45 losing up-close vision, or Presbyopia

    or distance vision and are time- consuming for practitioners to optimize

  • • Lifetime of management required, starting in young children

    • • US$3bn addressable market in US, large OUS markets

  • • US$2bn addressable market in US, ~$10bn China, plus other large OUS markets

3

Dr. David J. Mazzo

Brian Lane

Chairman and Non-executive Director

Chief Operating and ChiefDr. Ashley Tuan Chief Medical Officer

Financial Officer

  • • 40 years of experience in the life sciences industry

    • • CFO with extensive track record of strong financial results.

  • • Currently President,

    CEO and Executive Director of Caladrius Biosciences (NASDAQ:CLBS) and Board member of 2 NASDAQ-listed companies

    • • CFO of a private equity-backed company and CAO of multiple public companies

      • • 27 years experience in clinical and vision research; previously VP at Mojo Vision, a smart contact lens company

    • • Career foundation built on 11 years with

      • • Part of CooperVision team that enabled the launch of their MiSight contact lens

    • EY

      • • Member of ARVO & BCLA, and Fellow of the AAO.

  • • Previously served as

    CEO of several public companies, including leading Regado through its IPO

  • • Bachelor of Business Administration,

    • • Masters degree in Physiological Optics, Doctor of

  • Accounting from University of Georgia

  • Optometry from The Ohio State University, PhD in Vision Science from Univ of California at Berkeley

4

Mike Tilleli National Sales DirectorPam Pritchard Executive Director - SalesLayna Mendlinger Global Head of Marketing

Heather Hale

Controller

Operations

  • • Leads VTI sales team for North

    America

    • • Extensive experience in the contact lens industry.

      • • 30+ years experience in marketing management

        • • CPA with 20+ years experience in financial management

  • • Over 40 years of optical industry experience, primarily with Alcon, formerly CIBA Vision, CooperVision and IDOC.

    • • Nearly 30 years with Alcon, formerly

      • • Previously with Alcon, formerly

  • • Bachelor of Arts in Business &

    Managerial Economics from City University of New York - Queens College

  • CIBA Vision. Held management positions in Strategic Accounts; Planning, Communications & Operations; Inside Sales; Sales Training; and was a Senior Sales Representative

  • CIBA Vision, progressing from Brand Manager to Global Marketing Senior Director - New Product Development

    • • Past Controller for a multi-state surgery centre practice / management company

    • • Began career progressing to Manager at

      Deloitte, then to Accounting Manager at The Coca-Cola Company.

    • • MBA, Finance and Bachelor of

      Business Administration, Marketing from The University of Akron

  • • Bachelor of Arts in Advertising from the University of Georgia; Executive Education - Brand Management Program, Emory University, Goizueta School of Business

  • • Bachelor of Science degree in

    Accounting from Louisiana State University

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Visioneering Technologies Inc. published this content on 21 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 April 2022 22:37:08 UTC.